Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Moodys
Baxter
Medtronic
Mallinckrodt

Last Updated: December 8, 2021

DrugPatentWatch Database Preview

Patent: 10,517,933

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 10,517,933
Title:Method of treating androgen receptor negative prostate tumors and their metastases
Abstract: The invention includes a method of preventing or treating metastasis in a subject diagnosed with prostate cancer. In certain embodiments, the metastasis comprises bone cancer. In other embodiments, the subject suffers from castration-resistant prostate cancer.
Inventor(s): Fatatis; Alessandro (Penn Valley, PA), Jernigan; Danielle (Ardmore, PA), Shahriari; Kristina Susan (Philadelphia, PA), Shen; Fei (Philadelphia, PA)
Assignee: Drexel University (Philadelphia, PA)
Application Number:15/566,031
Patent Claims:see list of patent claims

Details for Patent 10,517,933

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Swedish Orphan Biovitrum Ab (publ) KINERET anakinra Injection 103950 2001-11-14 ⤷  Free Forever Trial 2035-05-12
Kiniksa Pharmaceuticals (uk), Ltd. ARCALYST rilonacept For Injection 125249 2008-02-27 ⤷  Free Forever Trial 2035-05-12
Novartis Pharmaceuticals Corporation ILARIS canakinumab For Injection 125319 2009-06-17 ⤷  Free Forever Trial 2035-05-12
Novartis Pharmaceuticals Corporation ILARIS canakinumab Injection 125319 2016-12-22 ⤷  Free Forever Trial 2035-05-12
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Medtronic
Baxter
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.